BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26850479)

  • 1. A next-generation sequencing gene panel (MiamiOtoGenes) for comprehensive analysis of deafness genes.
    Tekin D; Yan D; Bademci G; Feng Y; Guo S; Foster J; Blanton S; Tekin M; Liu X
    Hear Res; 2016 Mar; 333():179-184. PubMed ID: 26850479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deafness in the genomics era.
    Shearer AE; Hildebrand MS; Sloan CM; Smith RJ
    Hear Res; 2011 Dec; 282(1-2):1-9. PubMed ID: 22016077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carrier re-sequencing reveals rare but benign variants in recessive deafness genes.
    He L; Pang X; Chen P; Wang X; Yang T; Wu H
    Sci Rep; 2017 Sep; 7(1):11355. PubMed ID: 28900111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Validation of a Next-Generation Sequencing Panel for Syndromic and Nonsyndromic Hearing Loss.
    Butz M; McDonald A; Lundquist PA; Meyer M; Harrington S; Kester S; Stein MI; Mistry NA; Zimmerman Zuckerman E; Niu Z; Schimmenti L; Hasadsri L; Boczek NJ
    J Appl Lab Med; 2020 May; 5(3):467-479. PubMed ID: 32445360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A targeted gene capture next-generation sequencing panel for genetic screening of newborns.
    Peng Q; Liu G; Zhu P; Wu C; He X; Li W; Rao C; Li S; Lu X
    J Pak Med Assoc; 2020 Oct; 70(10):1789-1794. PubMed ID: 33159754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of targeted gene capture and next-generation sequencing technologies in studies of human deafness and other genetic disabilities.
    Lin X; Tang W; Ahmad S; Lu J; Colby CC; Zhu J; Yu Q
    Hear Res; 2012 Jun; 288(1-2):67-76. PubMed ID: 22269275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-exome sequencing and its impact in hereditary hearing loss.
    Atik T; Bademci G; Diaz-Horta O; Blanton SH; Tekin M
    Genet Res (Camb); 2015 Mar; 97():e4. PubMed ID: 25825321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Next-Generation Sequencing of a Deafness Gene Panel (MiamiOtoGenes) Analysis in Families Unsuitable for Linkage Analysis.
    Shang H; Yan D; Tayebi N; Saeidi K; Sahebalzamani A; Feng Y; Blanton S; Liu X
    Biomed Res Int; 2018; 2018():3103986. PubMed ID: 29568747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A low-cost exon capture method suitable for large-scale screening of genetic deafness by the massively-parallel sequencing approach.
    Tang W; Qian D; Ahmad S; Mattox D; Todd NW; Han H; Huang S; Li Y; Wang Y; Li H; Lin X
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):536-42. PubMed ID: 22480152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive genetic testing approach for major inherited kidney diseases, using next-generation sequencing with a custom panel.
    Mori T; Hosomichi K; Chiga M; Mandai S; Nakaoka H; Sohara E; Okado T; Rai T; Sasaki S; Inoue I; Uchida S
    Clin Exp Nephrol; 2017 Feb; 21(1):63-75. PubMed ID: 26920127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic screening of a Chinese cohort of children with hearing loss using a next-generation sequencing panel.
    Ma J; Ma X; Lin K; Huang R; Bi X; Ming C; Li L; Li X; Li G; Zhao L; Yang T; Gao Y; Zhang T
    Hum Genomics; 2023 Jan; 17(1):1. PubMed ID: 36597107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Exome Sequencing of Deafness Genes After Failure of Auditory Phenotype-Driven Candidate Gene Screening.
    Kim BJ; Kim AR; Park G; Park WY; Chang SO; Oh SH; Choi BY
    Otol Neurotol; 2015 Jul; 36(6):1096-102. PubMed ID: 25830873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted genomic capture and massively parallel sequencing to identify genes for hereditary hearing loss in Middle Eastern families.
    Brownstein Z; Friedman LM; Shahin H; Oron-Karni V; Kol N; Abu Rayyan A; Parzefall T; Lev D; Shalev S; Frydman M; Davidov B; Shohat M; Rahile M; Lieberman S; Levy-Lahad E; Lee MK; Shomron N; King MC; Walsh T; Kanaan M; Avraham KB
    Genome Biol; 2011 Sep; 12(9):R89. PubMed ID: 21917145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of genes for inherited hearing loss in the Israeli Jewish population, including the novel human deafness gene ATOH1.
    Brownstein Z; Gulsuner S; Walsh T; Martins FTA; Taiber S; Isakov O; Lee MK; Bordeynik-Cohen M; Birkan M; Chang W; Casadei S; Danial-Farran N; Abu-Rayyan A; Carlson R; Kamal L; Arnthórsson AÖ; Sokolov M; Gilony D; Lipschitz N; Frydman M; Davidov B; Macarov M; Sagi M; Vinkler C; Poran H; Sharony R; Samra N; Zvi N; Baris-Feldman H; Singer A; Handzel O; Hertzano R; Ali-Naffaa D; Ruhrman-Shahar N; Madgar O; Sofrin-Drucker E; Peleg A; Khayat M; Shohat M; Basel-Salmon L; Pras E; Lev D; Wolf M; Steingrimsson E; Shomron N; Kelley MW; Kanaan MN; Allon-Shalev S; King MC; Avraham KB
    Clin Genet; 2020 Oct; 98(4):353-364. PubMed ID: 33111345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.
    Au CH; Wa A; Ho DN; Chan TL; Ma ES
    Diagn Pathol; 2016 Jan; 11():11. PubMed ID: 26796102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance evaluation of the next-generation sequencing approach for molecular diagnosis of hereditary hearing loss.
    Sivakumaran TA; Husami A; Kissell D; Zhang W; Keddache M; Black AP; Tinkle BT; Greinwald JH; Zhang K
    Otolaryngol Head Neck Surg; 2013 Jun; 148(6):1007-16. PubMed ID: 23525850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients.
    Lim EC; Brett M; Lai AH; Lee SP; Tan ES; Jamuar SS; Ng IS; Tan EC
    Hum Genomics; 2015 Dec; 9():33. PubMed ID: 26666243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive functional network analysis and screening of deleterious pathogenic variants in non-syndromic hearing loss causative genes.
    Ray M; Sarkar S; Sable MN
    Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34714320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis.
    Schenkel LC; Kerkhof J; Stuart A; Reilly J; Eng B; Woodside C; Levstik A; Howlett CJ; Rupar AC; Knoll JHM; Ainsworth P; Waye JS; Sadikovic B
    J Mol Diagn; 2016 Sep; 18(5):657-667. PubMed ID: 27376475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.